Evaluation of Access Disparities to Biologic Disease-Modifying Antirheumatic Drugs in Rural and Urban Communities

The American College of Rheumatology guidelines provides a strong recommendation for the use of biologic disease-modifying antirheumatic drugs (bDMARDs) when conventional rheumatoid arthritis treatments fail to meet treatment targets. Although bDMARDs are an effective and important treatment compone...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterman, Nicholas J, Vashi, Aksal, Govan, Devan, Bhatia, Amrit, Vashi, Tejal, Kaptur, Brad, Yeo, Eunhae G, Gizinski, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339343/
https://www.ncbi.nlm.nih.gov/pubmed/35923666
http://dx.doi.org/10.7759/cureus.26448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339343/
https://www.ncbi.nlm.nih.gov/pubmed/35923666
http://dx.doi.org/10.7759/cureus.26448

Ejemplares similares